Hip Fracture Study of GSK576428 (Fondaparinux Sodium)

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05794165` - Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism	Phase 2
Active, not recruiting	`NCT05563883` - Atrial Fibrillation and Cancer: a Nationwide French Cohort Study
Terminated	`NCT02475187` - Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture
Recruiting	`NCT00982514` - Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008	N/A
Completed	`NCT01420809` - Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection	N/A
Terminated	`NCT00206089` - Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events	Phase 3
Completed	`NCT00014352` - Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer	Phase 2
Completed	`NCT00000614` - Prevention of Recurrent Venous Thromboembolism (PREVENT)	Phase 3
Active, not recruiting	`NCT05656963` - The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD
Completed	`NCT04719182` - Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19
Completed	`NCT02935751` - Apixaban Discontinuation Prior to Major Surgery
Terminated	`NCT02579122` - REVIparin-BRIDging-in a General Practice Setting in GErmany
Completed	`NCT01696760` - Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology	N/A
Completed	`NCT00986154` - Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).	Phase 3
Terminated	`NCT00662688` - Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer	Phase 3
Completed	`NCT00260988` - A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery	Phase 2/Phase 3
Terminated	`NCT00031837` - Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer	Phase 3
Completed	`NCT03877770` - DVT After Cardiac Procedure
Completed	`NCT00024297` - Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters	N/A
Recruiting	`NCT06118957` - Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery	Phase 2

NCT number	NCT00320424
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 3
Start date	February 16, 2006
Completion date	October 26, 2006

Hip Fracture Study of GSK576428 (Fondaparinux Sodium)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms